Semler Scientific to Deploy $500M in Bitcoin as a Hedge Against Traditional Risk

Semler Scientific is doubling down on Bitcoin. The medical tech firm announced plans to raise as much as $500 million by issuing new debt—funds it will channel into both its operational needs and a larger Bitcoin position.

The SEC filing reveals a long-term vision: not just holding BTC, but weaving it into the company’s corporate DNA. With Bitcoin already on its books, Semler is clearly betting on digital gold to play a growing role in its governance model.

With 3,192 BTC on its books—worth an estimated $265 million—Semler Scientific is standing firm on its crypto strategy. Though market volatility has triggered an unrealized loss of nearly $41.8 million, the company’s board, led by Chairman Eric Semler, sees Bitcoin as a strategic asset poised to strengthen Semler’s long-term financial footing.

Semler’s move mirrors a larger trend taking shape across global markets. Strategy, the company once known as MicroStrategy, recently expanded its Bitcoin holdings by 3,459 BTC—worth $285 million—while Japan’s Metaplanet is charting a similar course. These moves point to a deeper evolution in the financial world, where Bitcoin is no longer fringe but a growing part of corporate diversification strategies.

In a move to optimize reserve management, Semler Scientific has finalized a master agreement with Coinbase. The arrangement permits the company to use its Bitcoin as collateral to secure credit, which will be applied toward a $29.75 million settlement with the U.S. Department of Justice regarding prior marketing activities involving the QuantaFlo product.

Check this out: The Bitcoin Billionaire—How Michael Saylor Bet It All

While the company advances its Bitcoin strategy and prepares for settlement proceedings, it remains under financial pressure. Q1 2025 figures from Investing indicate operating losses between $1.3 million and $1.5 million, despite achieving a gross margin of 91.55%. Primary drivers of the losses include legal expenditures and non-cash reward liabilities.

Our stock price has been and is likely to continue to be volatile. The stock market in general and the market for smaller medical device companies in particular have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. With the adoption of our new bitcoin strategy, we expect to see additional volatility,

Semler Scientific noted in its official disclosure.

Against a backdrop of fiscal headwinds, the decision to expand its Bitcoin position is striking. More than just a hedge, it reflects a leadership eager to modernize its financial DNA. On a strategic level, the investment could redefine how the market perceives Semler—as a company aligned not with legacy finance, but with digital innovation.

Read on: What Are Assets? Differences Between Coins and Tokens